JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.17% |
| 2 | Healthcare | 10.79% |
| 3 | Financials | 9.36% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
CALL
Carvana
CVNA
$83.1B
| $1.51M | ﹤0.01% |
774,000
-1,031,500
| -57% | -$1.79M |
|
3577
WisdomTree International Equity Fund
DWM
$694M
| $1.51M | ﹤0.01% |
30,425
+2,953
| +11% | +$146K |
|
3578
Oaktree Specialty Lending
OCSL
$1.14B
| $1.51M | ﹤0.01% |
80,503
+70,535
| +708% | +$1.4M |
|
3579
PUT
Skyworks Solutions
SWKS
$10.5B
| $1.51M | ﹤0.01% |
12,800
-67,900
| -84% | -$7.52M |
|
3580
Martin Midstream Partners
MMLP
$93.9M
| $1.51M | ﹤0.01% |
550,873
-30,030
| -5% | -$85.9K |
|
3581
Haleon
HLN
$42.7B
| $1.51M | ﹤0.01% |
185,307
+69,706
| +60% | +$556K |
|
3582
PUT
Teradyne
TER
$65.5B
| $1.5M | ﹤0.01% |
+14,000
| New | +$1.43M |
|
3583
Pegasystems
PEGA
$5.31B
| $1.5M | ﹤0.01% |
62,052
-157,218
| -72% | -$3.31M |
|
3584
CALL
Alnylam Pharmaceuticals
ALNY
$30.6B
| $1.5M | ﹤0.01% |
+7,500
| New | +$1.58M |
|
3585
Quanterix
QTRX
$122M
| $1.5M | ﹤0.01% |
133,240
-8,811
| -6% | -$113K |
|
3586
CALL
Legend Biotech
LEGN
$3.95B
| $1.5M | ﹤0.01% |
31,000
-171,000
| -85% | -$8.36M |
|
3587
Titan International
TWI
$445M
| $1.5M | ﹤0.01% |
142,609
+97,268
| +215% | +$1.38M |
|
3588
SandRidge Energy
SD
$520M
| $1.49M | ﹤0.01% |
103,659
+16,608
| +19% | +$254K |
|
3589
RCI Hospitality Holdings
RICK
$236M
| $1.49M | ﹤0.01% |
19,051
+1,287
| +7% | +$112K |
|
3590
PUT
Teladoc Health
TDOC
$1.24B
| $1.48M | ﹤0.01% |
57,300
-27,400
| -32% | -$733K |
|
3591
Milestone Pharmaceuticals
MIST
$137M
| $1.48M | ﹤0.01% |
376,054
+46,330
| +14% | +$169K |
|
3592
JPMorgan US Value Factor ETF
JVAL
$874M
| $1.48M | ﹤0.01% |
43,374
+15,017
| +53% | +$516K |
|
3593
Napco Security Technologies
NSSC
$1.37B
| $1.48M | ﹤0.01% |
39,300
+2,310
| +6% | +$73.6K |
|
|
TGI
3594
DELISTED
Triumph Group
TGI
| $1.48M | ﹤0.01% |
127,413
+61,284
| +93% | +$698K |
|
|
CELL
3595
DELISTED
PhenomeX Inc. Common Stock
CELL
| $1.48M | ﹤0.01% |
1,273,536
-118,259
| -8% | -$216K |
|
3596
Lyell Immunopharma
LYEL
$342M
| $1.48M | ﹤0.01% |
31,250
+2,643
| +9% | +$141K |
|
3597
Sasol
SSL
$7.39B
| $1.48M | ﹤0.01% |
108,051
+103,228
| +2,140% | +$1.6M |
|
3598
PUT
Dollar General
DG
$27.2B
| $1.47M | ﹤0.01% |
7,000
-25,700
| -79% | -$5.77M |
|
|
CLDT
3599
Chatham Lodging
CLDT
$605M
| $1.47M | ﹤0.01% |
140,301
+22,197
| +19% | +$271K |
|
3600
PUT
NextEra Energy
NEE
$180B
| $1.47M | ﹤0.01% |
19,100
-55,200
| -74% | -$4.25M |
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 752 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 752 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.